Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Cardiovascular disease in an adenine-induced model of chronic kidney disease: the temporal link between vascular calcification and haemodynamic consequences.

Shobeiri N, Pang J, Adams MA, Holden RM.

J Hypertens. 2013 Jan;31(1):160-8. doi: 10.1097/HJH.0b013e32835b15bb.

PMID:
23183279
2.

Reduction of heart rate by omega-3 fatty acids and the potential underlying mechanisms.

Kang JX.

Front Physiol. 2012 Oct 30;3:416. doi: 10.3389/fphys.2012.00416.

3.

Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis.

Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS.

JAMA. 2012 Sep 12;308(10):1024-33. doi: 10.1001/2012.jama.11374. Review.

PMID:
22968891
4.

Omega-3 fatty acid supplementation increases 1,25-dihydroxyvitamin D and fetuin-A levels in dialysis patients.

An WS, Lee SM, Son YK, Kim SE, Kim KH, Han JY, Bae HR, Rha SH, Park Y.

Nutr Res. 2012 Jul;32(7):495-502. doi: 10.1016/j.nutres.2012.06.005.

PMID:
22901557
5.

Omega-3 long-chain polyunsaturated fatty acids supplementation on inflammatory biomakers: a systematic review of randomised clinical trials.

Rangel-Huerta OD, Aguilera CM, Mesa MD, Gil A.

Br J Nutr. 2012 Jun;107 Suppl 2:S159-70. doi: 10.1017/S0007114512001559. Review.

PMID:
22591890
6.

The effects of fish oil supplementation on markers of inflammation in chronic kidney disease patients.

Deike E, Bowden RG, Moreillon JJ, Griggs JO, Wilson RL, Cooke M, Shelmadine BD, Beaujean AA.

J Ren Nutr. 2012 Nov;22(6):572-7. doi: 10.1053/j.jrn.2011.10.036.

PMID:
22285316
7.

Effect of omega-3 fatty acids on the modification of erythrocyte membrane fatty acid content including oleic acid in peritoneal dialysis patients.

An WS, Lee SM, Son YK, Kim SE, Kim KH, Han JY, Bae HR, Park Y.

Prostaglandins Leukot Essent Fatty Acids. 2012 Jan-Feb;86(1-2):29-34. doi: 10.1016/j.plefa.2011.10.009.

PMID:
22071008
8.

Association between vascular calcification scores on plain radiographs and fatty acid contents of erythrocyte membrane in hemodialysis patients.

Son YK, Lee SM, Kim SE, Kim KH, Lee SY, Bae HR, Han JY, Park Y, An WS.

J Ren Nutr. 2012 Jan;22(1):58-66. doi: 10.1053/j.jrn.2011.01.023.

PMID:
21620727
9.

Vitamin D status and mortality risk in patients with chronic kidney disease.

Santoro D, Gitto L, Ferraro A, Satta E, Savica V, Bellinghieri G.

Ren Fail. 2011;33(2):184-91. doi: 10.3109/0886022X.2011.553303.

PMID:
21332341
10.

Eicosapentaenoic acid reduces warfarin-induced arterial calcification in rats.

Kanai S, Uto K, Honda K, Hagiwara N, Oda H.

Atherosclerosis. 2011 Mar;215(1):43-51. doi: 10.1016/j.atherosclerosis.2010.12.001.

PMID:
21193197
11.

n-3 fatty acids and cardiovascular events after myocardial infarction.

Kromhout D, Giltay EJ, Geleijnse JM; Alpha Omega Trial Group..

N Engl J Med. 2010 Nov 18;363(21):2015-26. doi: 10.1056/NEJMoa1003603.

12.

Effects of omega-3 on lipid profile and inflammation markers in peritoneal dialysis patients.

Hassan KS, Hassan SK, Hijazi EG, Khazim KO.

Ren Fail. 2010;32(9):1031-5. doi: 10.3109/0886022X.2010.510231.

PMID:
20863205
13.

Serum vitamin D levels and survival of patients with colorectal cancer: post-hoc analysis of a prospective cohort study.

Mezawa H, Sugiura T, Watanabe M, Norizoe C, Takahashi D, Shimojima A, Tamez S, Tsutsumi Y, Yanaga K, Urashima M.

BMC Cancer. 2010 Jul 2;10:347. doi: 10.1186/1471-2407-10-347.

14.

Fish oil and rheumatoid arthritis: past, present and future.

James M, Proudman S, Cleland L.

Proc Nutr Soc. 2010 Aug;69(3):316-23. doi: 10.1017/S0029665110001564. Review.

PMID:
20509981
15.

Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes.

Kayaniyil S, Vieth R, Retnakaran R, Knight JA, Qi Y, Gerstein HC, Perkins BA, Harris SB, Zinman B, Hanley AJ.

Diabetes Care. 2010 Jun;33(6):1379-81. doi: 10.2337/dc09-2321. Erratum in: Diabetes Care. 2011 Jan;34(1):247.

16.

25-hydroxyvitamin D levels, race, and the progression of kidney disease.

Melamed ML, Astor B, Michos ED, Hostetter TH, Powe NR, Muntner P.

J Am Soc Nephrol. 2009 Dec;20(12):2631-9. doi: 10.1681/ASN.2009030283.

17.

The effects of [omega]3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: a randomized controlled trial.

Mori TA, Burke V, Puddey I, Irish A, Cowpland CA, Beilin L, Dogra G, Watts GF.

J Hypertens. 2009 Sep;27(9):1863-72.

PMID:
19705518
18.

Vitamin D and the cardiovascular system.

Artaza JN, Mehrotra R, Norris KC.

Clin J Am Soc Nephrol. 2009 Sep;4(9):1515-22. doi: 10.2215/CJN.02260409. Review.

19.

Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney.

An WS, Kim HJ, Cho KH, Vaziri ND.

Am J Physiol Renal Physiol. 2009 Oct;297(4):F895-903. doi: 10.1152/ajprenal.00217.2009.

20.

Comparison of fatty acid contents of erythrocyte membrane in hemodialysis and peritoneal dialysis patients.

An WS, Kim SE, Kim KH, Lee S, Park Y, Kim HJ, Vaziri ND.

J Ren Nutr. 2009 Jul;19(4):267-74. doi: 10.1053/j.jrn.2009.01.027.

PMID:
19539181

Supplemental Content

Support Center